Product
Help
Pricing
About
Jobs
Log in
Get started
Keyword
Add to collection
p4EBP1
Description:
A phosphorylated form of 4E-binding protein 1, a regulator of translation controlled by the mTOR signaling pathway.
Primary topic:
PI3K/AKT/mTOR signaling in cancer (34%)
Related topics:
PI3K/AKT/mTOR signaling in cancer (34%),
HER2/EGFR in Cancer Research (7%)
OpenAlex ID:
keywords/p4ebp1
Dual targeting of AKT and mammalian target of rapamycin: A potential therapeutic approach for malignant peripheral nerve sheath tumor
2009
·
Changye Y. Zou
, Kerrington D. Smith
, et al.
·
Molecular Cancer Therapeutics
·
93
Translational studies within the TAMRAD randomized GINECO trial: evidence for mTORC1 activation marker as a predictive factor for everolimus efficacy in advanced breast cancer
2014
·
I. Treilleux
, M. Arnedos
, et al.
·
Annals of Oncology
·
92
Increased mTOR activation in idiopathic multicentric Castleman disease
2020
·
Daniel J. Arenas
, Katherine Floess
, et al.
·
Blood
·
88
PDF
Evaluation of the mTOR pathway in ocular (uvea and conjunctiva) melanoma
2010
·
Helena Pópulo
, Paula Soares
, et al.
·
Melanoma Research
·
86
TNF stimulates IL ‐6, CXCL 8 and VEGF secretion from human keratinocytes via activation of mTOR , inhibited by tetramethoxyluteolin
2018
·
Arti B. Patel
, Irene Tsilioni
, et al.
·
Experimental Dermatology
·
73
Dual Targeting of mTOR and Aurora-A Kinase for the Treatment of Uterine Leiomyosarcoma
2012
·
Kari J. Brewer Savannah
, Elizabeth G. Demicco
, et al.
·
Clinical Cancer Research
·
56
PI 3K– AKT – mTOR pathway proteins are differently expressed in oral carcinogenesis
2016
·
Fabiana Martins
, Suzana COM de Sousa
, et al.
·
Journal of Oral Pathology and Medicine
·
55
Integrated Analysis of PTEN and p4EBP1 Protein Expression as Predictors for pCR in HER2-Positive Breast Cancer
2016
·
Sibylle Loibl
, Silvia Darb-Esfahani
, et al.
·
Clinical Cancer Research
·
52
Human Mesenchymal Stem Cell-derived Exosomes Reduce Ischemia/Reperfusion Injury by the Inhibitions of Apoptosis and Autophagy
2019
·
Xiaofei Jiang
, Kar-Sheng Lew
, et al.
·
Current Pharmaceutical Design
·
50
Effects of Intermittent and Chronic Calorie Restriction on Mammalian Target of Rapamycin (mTOR) and IGF-I Signaling Pathways in Mammary Fat Pad Tissues and Mammary Tumors
2011
·
Soner Dogan
, Anna C. Johannsen
, et al.
·
Nutrition and Cancer
·
48
Analysis of expression of PTEN/PI3K pathway and programmed cell death ligand 1 (PD-L1) in malignant pleural mesothelioma (MPM)
2016
·
S. Cedrés
, S. Ponce-Aix
, et al.
·
Lung Cancer
·
46
PIK3CA mutations are frequently observed in BRCAX but not BRCA2-associated male breast cancer
2013
·
Siddhartha Deb
, Hongdo Do
, et al.
·
Breast Cancer Research
·
34
PDF
First-in-human phase I trial of the dual mTORC1 and mTORC2 inhibitor AZD2014 in solid tumors.
2012
·
Udai Banerji
, Emma Jane Dean
, et al.
·
Journal of Clinical Oncology
·
34
Analysis of PI3K/mTOR Pathway Biomarkers and Their Prognostic Value in Women with Hormone Receptor–Positive, HER2-Negative Early Breast Cancer
2016
·
Hamdy A. Azim
, Loay Kassem
, et al.
·
Translational Oncology
·
33
PDF
AKT/mTORC2 Inhibition Activates FOXO1 Function in CLL Cells Reducing B-Cell Receptor-Mediated Survival
2019
·
Emilio Cosimo
, Anuradha Tarafdar
, et al.
·
Clinical Cancer Research
·
31
Histologic variability in solitary fibrous tumors reflects angiogenic and growth factor signaling pathway alterations
2015
·
Elizabeth G. Demicco
, Khalida Wani
, et al.
·
Human Pathology
·
22
Phase I expansion trial of an oral TORC1/TORC2 inhibitor (CC-223) in advanced solid tumors.
2013
·
Andrea Varga
, Monica M. Mita
, et al.
·
Journal of Clinical Oncology
·
22
Hotspot Mutations in DICER1 Causing GLOW Syndrome-Associated Macrocephaly via Modulation of Specific MicroRNA Populations Result in the Activation of PI3K/ATK/mTOR Signaling
2019
·
Steven D. Klein
, Julian A. Martinez-Agosto
·
MicroRNA
·
21
Abstract 917: AZD2014, a dual mTORC1 and mTORC2 inhibitor is differentiated from allosteric inhibitors of mTORC1 in ER+ breast cancer
2012
·
Sylvie M. Guichard
, Zoe Howard
, et al.
·
Cancer Research
·
21
Co-Targeting PIM Kinase and PI3K/mTOR in NSCLC
2021
·
Gillian Moore
, Clara Lightner
, et al.
·
Cancers
·
20
PDF
Sestrin-like protein from Dictyostelium discoideum is involved in autophagy under starvation stress
2018
·
S. Rafia
, S. Saran
·
Microbiological Research
·
20
PDF
Phase I trial of an oral TORC1/TORC2 inhibitor (CC-223) in advanced solid and hematologic cancers.
2012
·
Kent C. Shih
, Johanna C. Bendell
, et al.
·
Journal of Clinical Oncology
·
20
Randomized phase II trial of neoadjuvant everolimus in patients with high-risk localized prostate cancer
2019
·
Vadim S. Koshkin
, Maria C. Mir
, et al.
·
Investigational New Drugs
·
16
Intravesical dual PI3K/mTOR complex 1/2 inhibitor NVP-BEZ235 therapy in an orthotopic bladder cancer model
2015
·
MASASHI MATSUSHIMA
, EIJI KIKUCHI
, et al.
·
International Journal of Oncology
·
14
PDF
Assessment of PI3K/mTOR/AKT Pathway Elements to Serve as Biomarkers and Therapeutic Targets in Penile Cancer
2021
·
Anita Thomas
, Sascha Reetz
, et al.
·
Cancers
·
13
PDF
Show more works
View as search
Works count:
105
Citation count:
1,183
Year
Topic
Type